Immuron (IMRN) Change in Cash (2016 - 2024)
Immuron (IMRN) posted quarterly Change in Cash of -$2.6 million for Q4 2024, down 113.47% year-over-year from $19.3 million in Q1 2024, and down 113.47% quarter-over-quarter from -$1.2 million in Q4 2023.
Immuron (IMRN) Change in Cash (2016 - 2024) Analysis & Trends
Immuron's Change in Cash history runs 9 years deep, the most recent figure standing at -$2.6 million for Q4 2024.
- In Q4 2024, Change in Cash fell 113.47% year-over-year to -$2.6 million; the TTM figure through Dec 2024 stood at $10.0 million (down 72.5% YoY), while the FY2025 annual figure was -$8.8 million, down 59.19% from the prior year.
- Change in Cash for Q4 2024 stood at -$2.6 million, down from -$1.2 million in the prior quarter.
- The five-year high for Change in Cash was $23.9 million in Q4 2020, with the low at -$3.6 million in Q4 2022.
- The 5-year median for Change in Cash is -$1.2 million (2023), against an average of $6.8 million.
- The sharpest annual moves came in 2020 and 2022: Change in Cash soared 8005.28% in 2020, then sank 120.68% in 2022.
- Immuron's Change in Cash stood at $23.9 million in 2020, then slipped by 26.8% to $17.5 million in 2021, then tumbled by 120.68% to -$3.6 million in 2022, then surged by 66.28% to -$1.2 million in 2023, then plunged by 113.47% to -$2.6 million in 2024.
- Business Quant data shows IMRN's Change in Cash at -$2.6 million in Q4 2024, -$1.2 million in Q4 2023, and -$3.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.60 Mn |
| Dec 31, 2023 | -1.22 Mn |
| Dec 31, 2022 | -3.62 Mn |
| Dec 31, 2021 | 17.49 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2018 | -424,901.00 |
| Dec 31, 2017 | -2.68 Mn |
| Dec 31, 2016 | 612,906.48 |